Karl joins Epocrates from athenahealth after the company acquired Epocrates in March 2013. Previously, Karl led Business Development at athenahealth and was responsible for acquisitions and corporate strategy. Previously, Karl was President of IntrinsiQ Financial where he helped transform the company from an oncology EHR software company into the leading oncology informatics company. In 2007, he helped to successfully orchestrate the sale of IntrinsiQ to Accel‐KKR. Karl has an M.B.A from the Harvard Business School and graduated magna cum laude in economics from Amherst College.